Transition Therapeutics Inc. Announces Third Quarter Fiscal 2011 Financial Results

TORONTO, May 10, 2011 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. (“Transition” or the “Company”) (TSX:TTH) (Nasdaq:TTHI), a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets, today announced its financial results for the quarter ended March 31, 2011.

MORE ON THIS TOPIC